rs148241932
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_014467.3(SRPX2):c.1144G>A(p.Val382Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000581 in 1,205,492 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Publications
- rolandic epilepsy-speech dyspraxia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polymicrogyria, bilateral perisylvian, X-linkedInheritance: XL Classification: LIMITED Submitted by: G2P
- rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedInheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SRPX2 | ENST00000373004.5 | c.1144G>A | p.Val382Met | missense_variant | Exon 10 of 11 | 1 | NM_014467.3 | ENSP00000362095.3 | ||
| SRPX2 | ENST00000638920.1 | n.1147G>A | non_coding_transcript_exon_variant | Exon 9 of 10 | 5 | |||||
| SRPX2 | ENST00000640282.1 | c.142-1511G>A | intron_variant | Intron 2 of 2 | 5 | ENSP00000491188.1 |
Frequencies
GnomAD3 genomes AF: 0.0000371 AC: 4AN: 107803Hom.: 0 Cov.: 20 show subpopulations
GnomAD2 exomes AF: 0.0000109 AC: 2AN: 183343 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1097689Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363055 show subpopulations
GnomAD4 genome AF: 0.0000371 AC: 4AN: 107803Hom.: 0 Cov.: 20 AF XY: 0.0000331 AC XY: 1AN XY: 30199 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1144G>A (p.V382M) alteration is located in exon 10 (coding exon 9) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 1144, causing the valine (V) at amino acid position 382 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
This sequence change replaces valine with methionine at codon 382 of the SRPX2 protein (p.Val382Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs148241932, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at